These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9570379)

  • 1. A screening method of SH2 domain ligands and blockers using a solid phase binding.
    Koh WS; Yoon SY; Lee EK; Lee EK; Kwon BM; Kim JW; Han MY
    Cancer Lett; 1997 Nov; 120(1):1-7. PubMed ID: 9570379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structures of the SH2 domain of Grb2: highlight on the binding of a new high-affinity inhibitor.
    Nioche P; Liu WQ; Broutin I; Charbonnier F; Latreille MT; Vidal M; Roques B; Garbay C; Ducruix A
    J Mol Biol; 2002 Feb; 315(5):1167-77. PubMed ID: 11827484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in structural dynamics of the Grb2 adaptor protein upon binding of phosphotyrosine ligand to its SH2 domain.
    de Mol NJ; Catalina MI; Fischer MJ; Broutin I; Maier CS; Heck AJ
    Biochim Biophys Acta; 2004 Jul; 1700(1):53-64. PubMed ID: 15210125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of phosphopeptide ligands for the Src-homology 2 (SH2) domain of Grb2 by phage display.
    Gram H; Schmitz R; Zuber JF; Baumann G
    Eur J Biochem; 1997 Jun; 246(3):633-7. PubMed ID: 9219519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural and synthetic analogues of actinomycin D as Grb2-SH2 domain blockers.
    Kim HK; Nam JY; Han MY; Son KH; Choi JD; Kwon BM; Takusagawa HL; Huang Y; Takusagawa F
    Bioorg Med Chem Lett; 2000 Jul; 10(13):1455-7. PubMed ID: 10888331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of proline-rich tyrosine kinase 2 in platelet activation: tyrosine phosphorylation mostly dependent on alphaIIbbeta3 integrin and protein kinase C, translocation to the cytoskeleton and association with Shc through Grb2.
    Ohmori T; Yatomi Y; Asazuma N; Satoh K; Ozaki Y
    Biochem J; 2000 Apr; 347(Pt 2):561-9. PubMed ID: 10749687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of protein-protein interactions involved in the activation of the Shc/Grb-2 pathway by the ErbB-2 kinase.
    Ricci A; Lanfrancone L; Chiari R; Belardo G; Pertica C; Natali PG; Pelicci PG; Segatto O
    Oncogene; 1995 Oct; 11(8):1519-29. PubMed ID: 7478576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Grb2 binding to the different isoforms of Ret tyrosine kinase.
    Alberti L; Borrello MG; Ghizzoni S; Torriti F; Rizzetti MG; Pierotti MA
    Oncogene; 1998 Sep; 17(9):1079-87. PubMed ID: 9764818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein interactions of Src homology 2 (SH2) domain-containing inositol phosphatase (SHIP): association with Shc displaces SHIP from FcgammaRIIb in B cells.
    Tridandapani S; Pradhan M; LaDine JR; Garber S; Anderson CL; Coggeshall KM
    J Immunol; 1999 Feb; 162(3):1408-14. PubMed ID: 9973396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the Src homology 2 (SH2) domain and C-terminus tyrosine phosphorylation sites of SH2-containing inositol phosphatase (SHIP) in the regulation of insulin-induced mitogenesis.
    Wada T; Sasaoka T; Ishiki M; Hori H; Haruta T; Ishihara H; Kobayashi M
    Endocrinology; 1999 Oct; 140(10):4585-94. PubMed ID: 10499514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-based design of peptidomimetic ligands of the Grb2-SH2 domain.
    Schoepfer J; Gay B; Caravatti G; Garcia-Echeverria C; Fretz H; Rahuel J; Furet P
    Bioorg Med Chem Lett; 1998 Oct; 8(20):2865-70. PubMed ID: 9873638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro characterization of major ligands for Src homology 2 domains derived from protein tyrosine kinases, from the adaptor protein SHC and from GTPase-activating protein in Ramos B cells.
    Baumann G; Maier D; Freuler F; Tschopp C; Baudisch K; Wienands J
    Eur J Immunol; 1994 Aug; 24(8):1799-807. PubMed ID: 7519995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Membrane-targeting of signalling molecules by SH2/SH3 domain-containing adaptor proteins.
    Buday L
    Biochim Biophys Acta; 1999 Jul; 1422(2):187-204. PubMed ID: 10393272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gads is a novel SH2 and SH3 domain-containing adaptor protein that binds to tyrosine-phosphorylated Shc.
    Liu SK; McGlade CJ
    Oncogene; 1998 Dec; 17(24):3073-82. PubMed ID: 9872323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a solid-phase binding assay and identification of nonpeptide ligands for the FynB Src homology 2 domain.
    Kim HJ; Lee HH; Yoo HD; Hwa Lee J; Hong ST
    J Pharm Biomed Anal; 2002 Jan; 27(1-2):51-6. PubMed ID: 11682210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural basis for the high affinity of amino-aromatic SH2 phosphopeptide ligands.
    Rahuel J; García-Echeverría C; Furet P; Strauss A; Caravatti G; Fretz H; Schoepfer J; Gay B
    J Mol Biol; 1998 Jun; 279(4):1013-22. PubMed ID: 9642078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent inhibitory ligands of the GRB2 SH2 domain from recombinant peptide libraries.
    Hart CP; Martin JE; Reed MA; Keval AA; Pustelnik MJ; Northrop JP; Patel DV; Grove JR
    Cell Signal; 1999 Jun; 11(6):453-64. PubMed ID: 10400318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Actinomycin D as a novel SH2 domain ligand inhibits Shc/Grb2 interaction in B104-1-1 (neu*-transformed NIH3T3) and SAA (hEGFR-overexpressed NIH3T3) cells.
    Kim HK; Nam JY; Han MY; Lee EK; Choi JD; Bok SH; Kwon BM
    FEBS Lett; 1999 Jun; 453(1-2):174-8. PubMed ID: 10403397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tyrosine phosphorylation of shc in response to B cell antigen receptor engagement depends on the SHIP inositol phosphatase.
    Ingham RJ; Okada H; Dang-Lawson M; Dinglasan J; van Der Geer P; Kurosaki T; Gold MR
    J Immunol; 1999 Dec; 163(11):5891-5. PubMed ID: 10570274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of residues that control specific binding of the Shc phosphotyrosine-binding domain to phosphotyrosine sites.
    van der Geer P; Wiley S; Gish GD; Lai VK; Stephens R; White MF; Kaplan D; Pawson T
    Proc Natl Acad Sci U S A; 1996 Feb; 93(3):963-8. PubMed ID: 8577769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.